July 31, 2020
Article
A new study helps make clear what’s happening in the visual systems of patients with pediatric onset multiple sclerosis.
July 26, 2020
Article
Alemtuzumab did not appear to negatively impact pregnancy outcomes in women who took the therapy for relapsing-remitting multiple sclerosis prior to becoming pregnant.
July 24, 2020
Article
The researchers noted that these results can help inform therapeutic decision making and identify opportunities to address barriers to disease-modifying drug (DMD) adherence, which not only improves clinical outcomes but also reaps benefits when it comes to health care costs.
July 19, 2020
Article
By delivering helpful information and fostering online communities, social media may provide rehabilitation and psychological benefits for patients with multiple sclerosis (MS) who have depression, according to the results of a recent Iranian study.
July 18, 2020
Article
A new study suggests patients with multiple sclerosis (MS) will see their ability to walk decline more rapidly than their hand function.
July 17, 2020
Article
The review article highlights the many ways that multiple sclerosis (MS) affects women over the lifespan, from pregnancy to childbirth to menopause and beyond—and how both research and clinical practice fall short in meeting their needs.
July 11, 2020
Article
New research sheds light on how multiple sclerosis affects the work lives of people with the disease. The data show that these patients face higher risks of missed work, even for reasons not directly linked to the disease.
July 10, 2020
Article
A new study suggests that people living with multiple sclerosis (MS) are often concerned about the costs of their care, but they do not always raise the concern with their doctor.
July 03, 2020
Article
A study from Germany asked patients with multiple sclerosis (MS) about beliefs regarding immune treatments as well as their illness perceptions. Researchers sought to assess these beliefs to test the idea that they are closely connected to adherence behavior.
July 02, 2020
Article
Most patients who have multiple sclerosis (MS) begin with a relapsing-remitting phase and eventually transition to a secondary progressive phase. In between is believed to be a “transitional” phase, but scientists have yet to discover how to clearly identify patients in transition.